Dihydroouabain

Product Describtion:Dihydroouabain is a cardiac glycoside and an inhibitor of the sodium-potassium pump. By inhibiting the guanine nucleotide-binding (G) protein, this compound effectively modulates the activity of adenylate cyclase and phospholipase C enzymes. Consequently, the production of cyclic AMP and diacylglycerol is significantly reduced. Specification: 0.95 Molecular Formula: C29H46O12 Molecular Weight: 586.67 PubChem CID: 6852401 Isomeric SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6CC(=O)OC6)O)CO)O)O)O)O Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/D354341-SCI_86be0166bceda0177eb6e9a57ed23257.pdf

UPC:

51124104

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

Yes

WeightUOM:

LB

MPN:

D354341-50mg

CAS:

1183-35-3

Health Hazards:

Toxic

Product Size:

50mg

Hazard Statement Codes:

H301:H311:H331

Precautionary Statement Codes:

P261:P264:P270:P271:P280:P330:P302+P352:P304+P340:P361+P364:P405:P403+P233:P501